MLH1

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from MLH1 gene)
Jump to: navigation, search


MutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)
Identifiers
Symbol(s) MLH1; COCA2; FCC2; HNPCC; HNPCC2; MGC5172; hMLH1
External IDs OMIM: 120436 MGI101938 Homologene208
RNA expression pattern

Image:PBB GE MLH1 202520 s at tn.png

More reference expression data

Orthologs
Human Mouse
Entrez 4292 17350
Ensembl ENSG00000076242 ENSMUSG00000032498
Uniprot P40692 Q3TG77
Refseq NM_000249 (mRNA)
NP_000240 (protein)
NM_026810 (mRNA)
NP_081086 (protein)
Location Chr 3: 37.01 - 37.07 Mb Chr 9: 111.07 - 111.12 Mb
Pubmed search [1] [2]

MutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli), also known as MLH1, is a human gene. MLH1 is a gene commonly associated with hereditary nonpolyposis colorectal cancer.


This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). It is a human homolog of the E. coli DNA mismatch repair gene mutL, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Alternatively spliced transcript variants encoding different isoforms have been described, but their full-length natures have not been determined.[1]


It can also be associated with Turcot syndrome.

References

Further reading

  • Paraf F, Sasseville D, Watters AK, et al. (1995). "Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome.". Hum. Pathol. 26 (4): 422-7. PMID 7705822.
  • Kolodner RD (1996). "Mismatch repair: mechanisms and relationship to cancer susceptibility.". Trends Biochem. Sci. 20 (10): 397-401. PMID 8533151.
  • Peltomäki P, de la Chapelle A (1997). "Mutations predisposing to hereditary nonpolyposis colorectal cancer.". Adv. Cancer Res. 71: 93-119. PMID 9111864.
  • Papadopoulos N, Lindblom A (1997). "Molecular basis of HNPCC: mutations of MMR genes.". Hum. Mutat. 10 (2): 89-99. doi:<89::AID-HUMU1>3.0.CO;2-H 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.0.CO;2-H. PMID 9259192.
  • Kauh J, Umbreit J (2004). "Colorectal cancer prevention.". Current problems in cancer 28 (5): 240-64. PMID 15375803.
  • Warusavitarne J, Schnitzler M (2007). "The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.". International journal of colorectal disease 22 (7): 739-48. doi:10.1007/s00384-006-0228-0. PMID 17109103.
  • Niv Y (2007). "Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer.". World J. Gastroenterol. 13 (12): 1767-9. PMID 17465465.

See also

External links

Template:Biochemistry-stub


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages